ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,294.10
-0.42%
S&P ASX All Technology
3,845.90
-0.28%
Brent Oil
79.285
3.07%
US Dollar vs AUD
1.6276
0.74%
Bitcoin
94,735.91
2.52%
Pepperstone
Advertisement
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. E-therapeutics Plc (ETX) Share Price

E-therapeutics Plc

E-therapeutics Plc (ETX)

Eaton Vance Municipal Income 2028 Term Trust
Maurel Et Prom
9.00
0.00
(0.00%)
Closed 11 January 3:30AM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
9.00
Bid
9.00
Offer
9.50
Volume
0.00
0.00 Day's Range 0.00
8.80 52 Week Range 18.50
Market Cap
52.546M
Previous Close
9.00
Open
-
Last Trade
(O)
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
0.00
Shares Outstanding
583,844,162
Dividend Yield
-
PE Ratio
-4.71
Earnings Per Share (EPS)
-0.02
Revenue
318k
Net Profit
-11.17M

About E-therapeutics Plc

Sector
Coml Physical, Biologcl Resh
Industry
Coml Physical, Biologcl Resh
Website
www.etherapeutics.co.uk
Headquarters
London, Gbr
Founded
-
E-therapeutics Plc is listed in the Coml Physical, Biologcl Resh sector of the London Stock Exchange with ticker ETX. The last closing price for E-therapeutics was 9p. Over the last year, E-therapeutics shares have traded in a share price range of 8.80p to 18.50p.

E-therapeutics currently has 583,844,162 shares in issue. The market capitalisation of E-therapeutics is £52.55 million. E-therapeutics has a price to earnings ratio (PE ratio) of -4.71.

Ask ADVFN Intelligence (AI)

ETX Latest News

More News

e-therapeutics Announces Business Updates and Interim Results

e-therapeutics Announces Business Updates and Interim Results LONDON, Oct. 31, 2024 (GLOBE NEWSWIRE) -- e-therapeutics plc, a company integrating computational power and biological data to...

01 November 2024
UK Regulatory

AIM Cancellation - e-Therapeutics Plc

AIM 09 May 2024   NOTICE   09/05/2024 - 07:00   NOTICE OF CANCELLATION OF ADMISSION TO TRADING ON AIM   At the request of the company the following securities have been cancelled from trading...

09 May 2024
RNS Regulatory News

e-Therapeutics plc Last Day of Dealings on AIM

e-Therapeutics plc 08 May 2024       e-therapeutics plc   ("e-therapeutics" or "ETX" or the "Company")    Last Day of Dealings on AIM     London, UK, 8 May 2024 - e-therapeutics plc (AIM:...

08 May 2024
RNS Regulatory News

FTSE Russell e-therapeutics

FTSE Russell 03 May 2024       E-therapeutics (UK): Constituent Deletion Changes in FTSE UK Index Series 03 May 2024 Subject to the expected cancellation of trading on AIM for E-therapeutics...

04 May 2024
RNS Regulatory News

e-Therapeutics plc Result of General Meeting

e-Therapeutics plc 29 April 2024         e-therapeutics plc   ("e-therapeutics" or "ETX" or the "Company")    Result of General Meeting  Matched Bargain Settlement Facility     London, UK, 29...

29 April 2024
RNS Regulatory News

e-Therapeutics says company faces lack of interest as UK listing

e-Therapeutics PLC on Wednesday announced its intention to cancel its admission to AIM and instead explore the option ...

10 April 2024
Alliance News

e-Therapeutics plc Proposed Fundraise of £28.9m and Cancellation

e-Therapeutics plc 10 April 2024       This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 as it forms part of UK domestic law by virtue...

10 April 2024
RNS Regulatory News

e-Therapeutics plc Total Voting Rights

e-Therapeutics plc 31 January 2024     e-therapeutics plc ("e-therapeutics" or the "Company")   Total Voting Rights     London, UK, 31 January 2024 - e-therapeutics plc (AIM: ETX), a company...

01 February 2024
RNS Regulatory News

e-Therapeutics plc Exercise of Options and Issue of Equity

e-Therapeutics plc 24 January 2024 e-therapeutics plc ("e-therapeutics" or the "Company") Exercise of Options and Issue of Equity London, UK, 24 January 2024 - e-therapeutics...

24 January 2024
UK Regulatory

IN BRIEF: e-Therapeutics shares rise on strong financial year

C - Oxford, England-based computer-based drug discovery company - Says 2023 was "a year of significant execution and ...

16 January 2024
Alliance News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10099900DE
40099900DE
120099900DE
260099900DE
52-2.55-22.077922077911.5518.58.825473211.44926234DE
156-31.3-77.667493796540.341.4823211317.61358774DE
2605.6164.7058823533.448.43.2558020417.79123925DE

ETX - Frequently Asked Questions (FAQ)

What is the current E-therapeutics share price?
The current share price of E-therapeutics is 9.00p
How many E-therapeutics shares are in issue?
E-therapeutics has 583,844,162 shares in issue
What is the market cap of E-therapeutics?
The market capitalisation of E-therapeutics is GBP 52.55M
What is the 1 year trading range for E-therapeutics share price?
E-therapeutics has traded in the range of 8.80p to 18.50p during the past year
What is the PE ratio of E-therapeutics?
The price to earnings ratio of E-therapeutics is -4.71
What is the cash to sales ratio of E-therapeutics?
The cash to sales ratio of E-therapeutics is 180
What is the reporting currency for E-therapeutics?
E-therapeutics reports financial results in GBP
What is the latest annual turnover for E-therapeutics?
The latest annual turnover of E-therapeutics is GBP 318k
What is the latest annual profit for E-therapeutics?
The latest annual profit of E-therapeutics is GBP -11.17M
What is the registered address of E-therapeutics?
The registered address for E-therapeutics is 4 KINGDOM STREET, PADDINGTON, LONDON
What is the E-therapeutics website address?
The website address for E-therapeutics is www.etherapeutics.co.uk
Which industry sector does E-therapeutics operate in?
E-therapeutics operates in the COML PHYSICAL, BIOLOGCL RESH sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
SCGLSealand Capital Galaxy Limited
4.60p
(43.75%)
10.46M
APHAlliance Pharma Plc
61.10p
(37.77%)
39.55M
NFXNuformix Plc
0.065p
(36.84%)
93.97M
PRMProteome Sciences Plc
4.50p
(31.58%)
1.06M
RCGHRc365 Holding Plc
2.10p
(31.25%)
2.88M
NTQEnteq Technologies Plc
0.775p
(-75.00%)
7.81M
JWNGJaywing Plc
0.625p
(-58.33%)
1.91M
MFAIMindflair Plc
0.825p
(-28.88%)
119.03M
WBIWoodbois Limited
0.135p
(-22.86%)
447.57M
GEXGeorgina Energy Plc
6.625p
(-22.06%)
5.72M
TRPTower Resources Plc
0.0395p
(6.76%)
9.11B
NTVONativo Resources Plc
0.002p
(-9.09%)
1.27B
DGIDg Innovate Plc
0.0185p
(0.00%)
544.86M
WBIWoodbois Limited
0.135p
(-22.86%)
447.57M
MSMNMosman Oil And Gas Limited
0.033p
(-2.94%)
445.45M

Discussion

View Full Feed
FNM500K FNM500K 3 minutes ago
https://www.barrons.com/articles/bill-ackman-fannie-mae-stock-freddie-6e7141d6?siteid=yhoof2
FNMA
MartinLutherKing MartinLutherKing 4 minutes ago
Are you sure it’s a scam brother
RNAZ
georgejjl georgejjl 4 minutes ago
Anavex 3-71

Early treatment with an M1 and sigma-1 receptor agonist prevents cognitive decline ... displaying Alzheimer-like amyloid pathology

"...The application of the selective allosteric M1 muscarinic and sigma-1 receptor agonist, AF710B (aka ANAVEX3-71), has shown
AVXL
StockInfo11 StockInfo11 4 minutes ago
Vior Inc. (VIO.v VIORF) reports high-grade gold results from its ongoing +60,000m drill program at the Belleterre Gold Project, Quebec. Highlights include 15.9 g/t Au over 1.2m at Vein #12 and 10.4 g/t Au over 1.2m at the Aubelle target. Drilling confirmed 500m depth extensions, with plans to add a
VIO
BOREALIS BOREALIS 4 minutes ago
See photos of smoke, smoldering homes and flames as wildfires ravage Los Angeles area

By PETER PRENGAMAN, JAE C. HONG, JOHN LOCHER and ALYSSA GOODMAN
Updated 5:01 PM CST, January 10, 2025

Four days after powerful winds gave fuel to what began as small fires in
Fred Flies Fred Flies 5 minutes ago
This scam is still a thing?!
OZSC
Explosivo Explosivo 5 minutes ago
That’s a lot of words to say, “I’m old”
HMBL
nagoya1 nagoya1 6 minutes ago
Ouch? Duh! Ahhh? Ooops?
No pompoms but drippity drip.
Ask skaterboy how his job search is coming along with Nemia’s reference letter.
Fnma
FNMA
StockInfo11 StockInfo11 6 minutes ago
New Era Helium Corp. (NASDAQ: NEHC) is a production-stage helium supplier with 1.5 BCF of proven reserves on 137,000 acres in the Permian Basin. Operating 400 wells, NEHC has $113M in long-term offtake deals and is expanding with a helium plant and net-zero data center venture. Deck➡️ https://www.ne
NEHC
baerga baerga 6 minutes ago
CNSP @ .12 for next week last penny to not have a big run
CNSP
Meowza Meowza 7 minutes ago
Defensive much about your yogurt consumption?
AMRN
moondogaz moondogaz 8 minutes ago
Clouds don't fly..lol. but rumor has it musk is working on flying bears...lo-freekn-l....
HMBL
biotech_researcher biotech_researcher 8 minutes ago
How many more days can this stay below 1 dollar before it is delisted?
AMRN
gfp927z gfp927z 8 minutes ago
Derf, Healthcare costs in the US will always be in crisis as long as the average American is 50 lbs overweight, eats crappy processed 'food' laced with chemicals, and has 'leaky gut' due to the lack of a healthy gut microbiome. The US spends the most on healthcare, and has the least healthy popul
tw0122 tw0122 8 minutes ago
Live from style="font-size: 1em; caret-color: rgb(33, 37, 41); color: rgba(33, 37, 41, 1); font-family: arial, helvetica, sans-serif"SAN DIEGO style="caret-color: rgb(33, 37, 41); color: rgba(33, 37, 41, 1); font-family: arial, helvetica, sans-serif; font-size: medium; background-color: rgba
TRAW
Zorax Zorax 9 minutes ago
The only problem we have on the food front is cost, and that began with COVID.

Yes. And the other problem is corporations and smaller companies have gotten fat on the artificial high prices since.

Like walmart, wanting to and probably are raising prices across their sto
navycmdr navycmdr 9 minutes ago
Jan 16th nomination hearing for

Treasury Secretary Bessent ...

https://investorshub.advfn.com/uimage/uploads/2025/1/10/tueclScreenshot_20250110_153640_Chrome.jpg
FNMA
The Great Pumpkin The Great Pumpkin 10 minutes ago
I’d suggest you do some DD on what the private market thinks NLM is worth.

FAFO

#scam
LWLG
dinogreeves dinogreeves 10 minutes ago
Very much true. Permits will push it higher, but the most this will do after the permits is 38-48 cents, but according to you permits will take 240-270 days. They haven't even filed the amended application. FID is going to change everything and I stand by it. Forget what happened in the past.
TGLO
art2426 art2426 11 minutes ago
>>>If we get all three, Katie bar the door. The share price could explode in a heartbeat.
BIEL
The Great Pumpkin The Great Pumpkin 12 minutes ago
Good job. Stock is going back to .60.

FAFO

#scam
LWLG
Explosivo Explosivo 13 minutes ago
So you’re not some old dude? Huggy bear? Your name is a reference to a thing that most people here who are positive weren’t even alive for. Really? You’re fooling no one. At least admit it. You’re old. It’s ok.
HMBL
fuagf fuagf 14 minutes ago
Thomas, Alito, Gorsuch, Kavanaugh see kingship in Trump. Merchan, true patriot. Roberts and Barrett, firm.

"Judge upholds Trump’s felony conviction, but does not plan to order jail time
"Trump indictment follows 50 years of investigation on many fronts""

Relat

Your Recent History

LSE
ETX
E-therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads